Business Combinations and Goodwill (Tables)

6 Months Ended

Jun. 30, 2025

Business Combination and Asset Acquisition [Abstract]

Schedule of Business Acquisitions, by Acquisition

The following table summarizes the purchase price allocation of the fair value of assets acquired and liabilities assumed at the acquisition date (in thousands):

	AHMS
Total purchase consideration:
Cash paid	$	63,935
Purchase price due from seller		(2,995	)
	$	60,940
Assets:
Cash and cash equivalents	$	33,950
Receivables		11,007
Prepaid expenses and other current assets		36
Intangible assets		23,600
Goodwill		25,571
Restricted cash		300
Total assets acquired	$	94,464
Liabilities:
Accounts payable and accrued expenses	$	13,001
Medical liabilities		14,093
Deferred tax liability		6,430
Total liabilities assumed	$	33,524
Total net assets acquired	$	60,940

The following table summarizes the purchase price allocation of the fair value of assets acquired and liabilities assumed at the acquisition date (in thousands):

	CHS
Total purchase consideration:
Cash paid	$	35,322
Purchase price due to seller		6,944
Contingent consideration		5,154
Common stock issued and replacement awards		118
	$	47,538
Assets:
Cash and cash equivalents	$	4,556
Receivables		100,334
Other receivables		36,667
Prepaid expenses and other current assets		357
Intangible assets		14,200
Goodwill		9,976
Investments in other entities – equity method		2,846
Total assets acquired	$	168,936
Liabilities:
Accounts payable and accrued expenses	$	67,027
Medical liabilities		54,449
Non-controlling interest		(78	)
Total liabilities assumed	$	121,398
Total net assets acquired	$	47,538

Unaudited Pro Forma Financial Information

The pro forma financial information in the table below presents the combined results of the Company and the acquisitions that occurred during the year ended 2024, as if the acquisitions had occurred on January 1, 2024. The pro forma information presented is shown for illustrative purposes only and is not necessarily indicative of future results of operations of the Company, or results of operations of the Company that would have actually occurred had the transactions been in effect for the periods presented.

	Three Months Ended June 30,		Six Months Ended June 30,
(in thousands, except per share amounts)	2024		2024
Total revenue	$	693,823	$	1,372,463
Net income attributable to Astrana Health, Inc.	$	9,875	$	29,045
Net income per share – basic	$	0.21	$	0.61
Net income per share – diluted	$	0.21	$	0.61

Schedule of Change in Carrying Value of Goodwill

The change in the carrying value of goodwill for the six months ended June 30, 2025 was as follows (in thousands):

	Amount
Balance at January 1, 2025	$	419,253
Adjustments		(2,336	)
Balance at June 30, 2025	$	416,917